Ropivacaine is an aminoamide local anesthetic drug marketed by AstraZeneca under the trade name Naropin. It exists as a racemate of its S- and R-enantiomers, although the marketed form is supplied only as the purified S-enantiomer.
Ropivacaine is indicated in adult patients for the induction of regional or local anesthesia for surgery or acute pain management.
Duke University Hospital, Durham, North Carolina, United States
Government medical college, Haldwani, Uttarakhand, India
Memorial Sloan Kettering Cancer Center, New York, New York, United States
UZ Leuven, campus Gasthuisberg, Leuven, Belgium
Xulei CUI, Beijing, Beijing, China
Rigshospitalet, Copenhagen, Denmark
Maimonides Medical Center, Brooklyn, New York, United States
Obstetrics and Gynecology Hospital Affiliated to Nanjing Medical University, Nanjing, Jiangsu, China
The first affiliated hospital of Anhui Medical University, Hefei, Anhui, China
Texas Orthopedics, Austin, Texas, United States
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.